Paul B. Manning - Oct 13, 2022 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Director
Signature
/s/ Jason A. Amello, as Attorney-In-Fact for Paul B. Manning
Stock symbol
CADL
Transactions as of
Oct 13, 2022
Transactions value $
$0
Form type
4
Date filed
10/17/2022, 04:36 PM
Previous filing
Jul 5, 2022
Next filing
Nov 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CADL Stock Option (Right to Buy) Award $0 +14.2K $0.00 14.2K Oct 13, 2022 Common Stock 14.2K $2.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) October 13, 2023 or (ii) the date of the next Annual Meeting of Stockholders of the Company; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors of the Company or otherwise ceases to serve as a Director, unless the Board determines that the circumstances warrant continuation of vesting.

Remarks:

Exhibit 24 - Power of Attorney